Vaccines for Older Adults: Current Practices and Future Opportunities. Группа авторов

147Merani S, Kuchel GA, Kleppinger A, McElhaney JE: Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage. Exp Gerontol 2018;107:116–125.

148Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, et al; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN): Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: a pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network). Vaccine 2018;36:2166–2175.

149Moro-García MA, Alonso-Arias R, López-Vázquez A, Suárez-García FM, Solano-Jaurrieta JJ, Baltar J, López-Larrea C: Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age (Dordr) 2012;34:479–495.

150Furman D, Jojic V, Sharma S, Shen-Orr SS, Angel CJ, Onengut-Gumuscu S, Kidd BA, Maecker HT, Concannon P, Dekker CL, Thomas PG, Davis MM: Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med 2015;7:281ra43.

151Kastenmüller W, Torabi-Parizi P, Subramanian N, Lämmermann T, Germain RN: A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012;150:1235–1248.

152Wilder JA, Koh CY, Yuan D: The role of NK cells during in vivo antigen-specific antibody responses. J Immunol 1996;156:146–152.

153Hunter CA, Jones SA: IL-6 as a keystone cytokine in health and disease. Nat Immunol 2015;16:448–457.

154Bigley AB, Rezvani K, Shah N, Sekine T, Balneger N, Pistillo M, Agha N, Kunz H, O’Connor DP, Bollard CM, Simpson RJ: Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Clin Exp Immunol 2016;185:239–251.

155Bigley AB, Rezvani K, Shah N, Sekine T, Balneger N, Pistillo M, Agha N, Kunz H, O’Connor DP, Bollard CM, Simpson RJ: Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Clin Exp Immunol 2016;185:239–251.

156Kirkland JL, Tchkonia T, Zhu Y, Niedernhofer LJ, Robbins PD: The clinical potential of senolytic drugs. J Am Geriatr Soc 2017;65:2297–2301.

      Tamàs Fülöp, MD, PhD

      Research Center on Aging, Faculty of Medicine and Health Sciences

      University of Sherbrooke, 3001, 12th Avenue North

      Sherbrooke, QC J1H 5N4 (Canada)

      E-Mail [email protected]